1-20 of 73
Michael G. Brattain
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Retraction: Endogenous Control of Cell Cycle Progression by Autocrine Transforming Growth Factor β in Breast Cancer Cells

Sudhakar Ammanamanchi, Manoranjani P.M. Tillekeratne, Tien C. Ko, Michael G. Brattain
Journal: Cancer Research
Cancer Res (2019) 79 (5): 1016.
https://doi.org/10.1158/0008-5472.CAN-19-0071
Published: 01 March 2019
View article titled, Retraction: Endogenous Control of Cell Cycle Progression by Autocrine Transforming Growth Factor β in Breast Cancer Cells
Open the PDF for Retraction: Endogenous Control of Cell Cycle Progression by Autocrine Transforming Growth Factor β in Breast Cancer Cells in another window
Journal Articles

Abstract 4563: Role of ezrin in PKA dependent colorectal cancer cell fate

Premila Leiphrakpam, Michael G. Brattain
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4563.
https://doi.org/10.1158/1538-7445.AM2016-4563
Published: 15 July 2016
View article titled, Abstract 4563: Role of ezrin in PKA dependent colorectal cancer cell fate
Journal Articles

Abstract B60: Identification of the specific histone deacetylases involved in the silencing of transforming growth factor β receptor II in colon cancer

Catherine Murari, Gillian M. Howell, Michael G. Brattain
Journal: Cancer Research
Cancer Res (2013) 73 (13_Supplement): B60.
https://doi.org/10.1158/1538-7445.CEC13-B60
Published: 13 May 2014
View article titled, Abstract B60: Identification of the specific histone deacetylases involved in the silencing of transforming growth factor β receptor II in colon cancer
Journal Articles

Abstract 1005: Ron monoclonal antibody IMC-RON8 sensitizes pancreatic cancer to histone deacetylase inhibitors.

Yi Zou, Gillian M. Howell, Lisa E. Brattain, Jing Wang, Vinee Purohit, Pankaj Singh, Michael G. Brattain
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 1005.
https://doi.org/10.1158/1538-7445.AM2013-1005
Published: 15 April 2013
View article titled, Abstract 1005: Ron monoclonal antibody IMC-RON8 sensitizes pancreatic cancer to histone deacetylase inhibitors.
Journal Articles

Abstract 594: Dual regulation of cell death by Akt kinase inhibitor Mk-2206 in colorectal cancer.

Ekta Agarwal, Anathbandhu Chaudhuri, Michael G. Brattain, Sanjib Chowdhury
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 594.
https://doi.org/10.1158/1538-7445.AM2013-594
Published: 15 April 2013
View article titled, Abstract 594: Dual regulation of cell death by Akt kinase inhibitor Mk-2206 in colorectal cancer.
Journal Articles

Abstract 3887: The expression and clinical significance of Ezrin in colorectal cancer metastasis.

Premila Devi Leiphrakpam, Ashwani Rajput, Michael G. Brattain, Sanjib Chowdhury
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 3887.
https://doi.org/10.1158/1538-7445.AM2013-3887
Published: 15 April 2013
View article titled, Abstract 3887: The expression and clinical significance of Ezrin in colorectal cancer metastasis.
Journal Articles

Abstract 5262: The role of Bcl-2 in colon cancer metastatic progression

Wang Wang, Chandrakanth Are, Michael G. Brattain
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 5262.
https://doi.org/10.1158/1538-7445.AM2011-5262
Published: 15 April 2011
View article titled, Abstract 5262: The role of Bcl-2 in colon cancer metastatic progression
Journal Articles

Abstract 2009: Histone deacetylase inhibitors (HDI) down-regulate Ron kinase and synergize with Ron knockdown or Ron monoclonal antibody 41A10to treat pancreatic cancer

Yi Zou, Gillian Howell, Michael G. Brattain
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2009.
https://doi.org/10.1158/1538-7445.AM2011-2009
Published: 15 April 2011
View article titled, Abstract 2009: Histone deacetylase inhibitors (HDI) down-regulate Ron kinase and synergize with Ron knockdown or Ron monoclonal antibody 41A10to treat pancreatic cancer
Journal Articles

Abstract 3296: Cell survival in colon cancer metastatic progression

Wang Wang, Michael G. Brattain
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3296.
https://doi.org/10.1158/1538-7445.AM10-3296
Published: 15 April 2010
View article titled, Abstract 3296: Cell survival in colon cancer metastatic progression
Journal Articles

Abstract 3973: Identification of novel transduceome in TGFβ mediated IAP downregulation in colorectal cancer

Sanjib Chowdhury, Carol A. Smith, Michael G. Brattain, Gillian M. Howell
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3973.
https://doi.org/10.1158/1538-7445.AM10-3973
Published: 15 April 2010
View article titled, Abstract 3973: Identification of novel transduceome in TGFβ mediated IAP downregulation in colorectal cancer
Journal Articles

Heterogeneity of Receptor Function in Colon Carcinoma Cells Determined by Cross-talk between Type I Insulin-like Growth Factor Receptor and Epidermal Growth Factor Receptor

Yi Peter Hu, Sandip B. Patil, Michelle Panasiewicz, Wenhui Li, Jennie Hauser, Lisa E. Humphrey, Michael G. Brattain
Journal: Cancer Research
Cancer Res (2008) 68 (19): 8004–8013.
https://doi.org/10.1158/0008-5472.CAN-08-0280
Published: 30 September 2008
View article titled, Heterogeneity of Receptor Function in Colon Carcinoma Cells Determined by Cross-talk between Type I Insulin-like Growth Factor Receptor and Epidermal Growth Factor Receptor
Open the PDF for Heterogeneity of Receptor Function in Colon Carcinoma Cells Determined by Cross-talk between Type I Insulin-like Growth Factor Receptor and Epidermal Growth Factor Receptor in another window
Journal Articles

Transforming Growth Factor β Induces Apoptosis through Repressing the Phosphoinositide 3-Kinase/AKT/Survivin Pathway in Colon Cancer Cells

Jing Wang, Limin Yang, Junhua Yang, Karen Kuropatwinski, Wang Wang, Xiao-Qiong Liu, Jennie Hauser, Michael G. Brattain
Journal: Cancer Research
Cancer Res (2008) 68 (9): 3152–3160.
https://doi.org/10.1158/0008-5472.CAN-07-5348
Published: 01 May 2008
View article titled, Transforming Growth Factor β Induces Apoptosis through Repressing the Phosphoinositide 3-Kinase/AKT/Survivin Pathway in Colon Cancer Cells
Open the PDF for Transforming Growth Factor β Induces Apoptosis through Repressing the Phosphoinositide 3-Kinase/AKT/Survivin Pathway in Colon Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Mutant PIK3CA-Bearing Colon Cancer Cells Display Increased Metastasis in an Orthotopic Model

Xiao-Ning Guo, Ashwani Rajput, Rebecca Rose, Jennie Hauser, Alexander Beko, Karen Kuropatwinski, Charles LeVea, Robert M. Hoffman, Michael G. Brattain, Jing Wang
Journal: Cancer Research
Cancer Res (2007) 67 (12): 5851–5858.
https://doi.org/10.1158/0008-5472.CAN-07-0049
Published: 15 June 2007
View article titled, Mutant <em>PIK3CA</em>-Bearing Colon Cancer Cells Display Increased Metastasis in an Orthotopic Model
Open the PDF for Mutant <em>PIK3CA</em>-Bearing Colon Cancer Cells Display Increased Metastasis in an Orthotopic Model in another window
Journal Articles

A Novel Mechanism of Resistance to Epidermal Growth Factor Receptor Antagonism In vivo

Ashwani Rajput, Alan P. Koterba, Jeffrey I. Kreisberg, Jason M. Foster, James K.V. Willson, Michael G. Brattain
Journal: Cancer Research
Cancer Res (2007) 67 (2): 665–673.
https://doi.org/10.1158/0008-5472.CAN-06-2773
Published: 18 January 2007
View article titled, A Novel Mechanism of Resistance to Epidermal Growth Factor Receptor Antagonism <em>In vivo</em>
Open the PDF for A Novel Mechanism of Resistance to Epidermal Growth Factor Receptor Antagonism <em>In vivo</em> in another window
Journal Articles

The combination treatment with inhibitors targeting the type I insulin-like growth factor receptor and the epidermal growth factor receptor in human colon cancer.

Yi P. Hu, Qun-Sheng Ji, Julie Kan, Jing Wang, Yunfei Zhou, Jennie Hauser, Michelle Vinci, Neil Gibson, Michael G. Brattain
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1191.
Published: 15 April 2006
View article titled, The combination treatment with inhibitors targeting the type I insulin-like growth factor receptor and the epidermal growth factor receptor in human colon cancer.
Journal Articles

Integrin alpha 2-mediated ERK and calpain activation via FAK signaling (outside-in signaling) play critical role in cell adhesion and motility (inside-out signaling) in colon cancer cells

Rajinder S. Sawhney, Yasin Omar, Michelle Cookson, Majed Aggi, Jennie Hauser, Michael G. Brattain
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 799–800.
Published: 15 April 2006
View article titled, Integrin alpha 2-mediated ERK and calpain activation via FAK signaling (outside-in signaling) play critical role in cell adhesion and motility (inside-out signaling) in colon cancer cells
Journal Articles

Characterization of colon cancer cells bearing only wild-type or mutant PIK3CA allele

Xiao-Ning Guo, Jing Wang, Jennie Hauser, Michael G. Brattain
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 717.
Published: 15 April 2006
View article titled, Characterization of colon cancer cells bearing only wild-type or mutant PIK3CA allele
Journal Articles

RON tyrosine kinase: a potential target for colorectal cancer therapy

Ashwani Rajput, Rebecca Rose, Charles Levea, Alexander Beko, Michael G. Brattain, Jing Wang
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 633.
Published: 15 April 2006
View article titled, RON tyrosine kinase: a potential target for colorectal cancer therapy
Journal Articles

Blockade of EGFR and ErbB2 by the Novel Dual EGFR and ErbB2 Tyrosine Kinase Inhibitor GW572016 Sensitizes Human Colon Carcinoma GEO Cells to Apoptosis

Yunfei Zhou, Song Li, Yi P. Hu, Jing Wang, Jennie Hauser, Alexis N. Conway, Michelle A. Vinci, Lisa Humphrey, Elizabeth Zborowska, James K.V. Willson, Michael G. Brattain
Journal: Cancer Research
Cancer Res (2006) 66 (1): 404–411.
https://doi.org/10.1158/0008-5472.CAN-05-2506
Published: 05 January 2006
View article titled, Blockade of EGFR and ErbB2 by the Novel Dual EGFR and ErbB2 Tyrosine Kinase Inhibitor GW572016 Sensitizes Human Colon Carcinoma GEO Cells to Apoptosis
Open the PDF for Blockade of EGFR and ErbB2 by the Novel Dual EGFR and ErbB2 Tyrosine Kinase Inhibitor GW572016 Sensitizes Human Colon Carcinoma GEO Cells to Apoptosis in another window
Journal Articles

Synergy of Epidermal Growth Factor Receptor Kinase Inhibitor AG1478 and ErbB2 Kinase Inhibitor AG879 in Human Colon Carcinoma Cells Is Associated with Induction of Apoptosis

Yunfei Zhou, Michael G. Brattain
Journal: Cancer Research
Cancer Res (2005) 65 (13): 5848–5856.
https://doi.org/10.1158/0008-5472.CAN-04-3509
Published: 01 July 2005
View article titled, Synergy of Epidermal Growth Factor Receptor Kinase Inhibitor AG1478 and ErbB2 Kinase Inhibitor AG879 in Human Colon Carcinoma Cells Is Associated with Induction of Apoptosis
Open the PDF for Synergy of Epidermal Growth Factor Receptor Kinase Inhibitor AG1478 and ErbB2 Kinase Inhibitor AG879 in Human Colon Carcinoma Cells Is Associated with Induction of Apoptosis in another window